Welcome to Top of the Morning by Mint.. I’m Nelson John and here are today’s top stories. Ceasefire Cheers, Markets Rally Wall Street bounced and gold slumped as President Donald Trump brokered a surprise ceasefire between Israel and Iran—bringing an end to what he called the “12-Day War.” Investors cheered the cooling conflict, triggering a selloff in safe-haven assets. On the Multi Commodity Exchange (MCX), gold futures dropped sharply by ₹2,606 per 10 grams, while global gold prices echoed the dip. But the peace proved shaky—new explosions were reported in Tehran, adding fresh uncertainty. Analysts now expect continued volatility in bullion, with technical indicators flashing a bearish outlook. Trump Nominated for Nobel Peace Prize In a bold political twist, US Congressman Buddy Carter nominated Trump for the Nobel Peace Prize for his “extraordinary and historic” efforts in ending the Israel-Iran standoff. Carter praised Trump’s “courage and clarity” in averting a broader war and halting Iran’s nuclear momentum. While the prize remains far from guaranteed, the nomination adds a headline-grabbing chapter to Trump’s presidency—and could influence the global political narrative. DGCA Flags Grim Safety Lapses India’s skies are under scrutiny. In the wake of the June 12 Air India crash, the Directorate General of Civil Aviation (DGCA) launched a nationwide audit—and found alarming lapses. From repeated aircraft defects to worn-out tyres and faded runway markings, the audit revealed deep cracks in aviation safety protocols. Ground equipment was unserviceable, simulators didn’t match actual aircraft, and obstruction data hadn’t been updated in three years—despite ongoing construction near airports. The DGCA has ordered urgent fixes within a week and vowed continuous monitoring. With air traffic surging, the need for a full-scale aviation safety overhaul is more urgent than ever. Wegovy Enters India’s Obesity Fight Novo Nordisk has officially launched Wegovy in India—a once-a-week injectable weight loss drug targeting adults battling obesity and cardiovascular risks. Priced between ₹17,345 and ₹26,050, Wegovy enters a space already heating up with Eli Lilly’s Mounjaro, launched earlier this year. Unlike diabetes drug Ozempic, Wegovy is FDA-approved specifically for weight loss. The drug mimics appetite-suppressing hormones and boosts insulin sensitivity. Novo Nordisk says it’s focusing on awareness and accessibility rather than immediate sales numbers. As India’s obesity challenge deepens, a pharma face-off is brewing—one pen injection at a time. Hindalco Buys Into High-Tech Alumina Hindalco is going deeper into advanced materials. The Aditya Birla Group’s metals major has announced a $125 million acquisition of U.S.-based AluChem Companies Inc., adding 60,000 tonnes of specialty alumina capacity. AluChem’s products power EVs, semiconductors, and precision ceramics—critical segments in a fast-changing global supply chain. This marks Hindalco’s third U.S. metals acquisition after Novelis and Aleris. MD Satish Pai says the deal is part of a long-term plan to double Hindalco’s specialty alumina output to 1 million tonnes by FY30. “As clean-tech demand rises, AluChem’s chemistry will help us lead,” he said. Learn more about your ad choices. Visit megaphone.fm/adchoices